| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/07/2002 | EP1228232A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 08/07/2002 | EP1228231A1 Mammalian-type glycosylation in plants |
| 08/07/2002 | EP1228230A2 Method for enhancing resistance in plants |
| 08/07/2002 | EP1228229A2 Control of post-transcriptional gene silencing in plants |
| 08/07/2002 | EP1228228A2 Sorghum dwarfing genes and methods of use |
| 08/07/2002 | EP1228226A2 Genes and methods for manipulation of growth |
| 08/07/2002 | EP1228225A2 Modified resistance genes |
| 08/07/2002 | EP1228220A2 Educational kit and method containing alpha helical protein-34 |
| 08/07/2002 | EP1228219A2 Bacillus thuringiensis hybrid toxins |
| 08/07/2002 | EP1228217A2 Conserved neisserial antigens |
| 08/07/2002 | EP1228216A2 Plants with a modified flower and seed development |
| 08/07/2002 | EP1228215A1 Helical cytokine zalpha33 |
| 08/07/2002 | EP1228214A2 Erythropoietin forms with improved properties |
| 08/07/2002 | EP1228213A2 Protein having activity as an angiogenesis modulator |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228211A2 Crib protein zmse1 |
| 08/07/2002 | EP1228210A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 08/07/2002 | EP1228209A1 "insulin-responsive sequence dna binding protein-1" (irsdbp-1), gene encoding it and uses thereof |
| 08/07/2002 | EP1228208A2 36p6d5: secreted tumor antigen |
| 08/07/2002 | EP1228207A1 Novel human melastatin-like proteins and polynucleotides encoding the same |
| 08/07/2002 | EP1228206A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 08/07/2002 | EP1228205A2 Twik potassium channel molecules and uses therefor |
| 08/07/2002 | EP1228204A2 Smad associating polypeptides |
| 08/07/2002 | EP1228200A1 Production of functional hybrid genes and proteins |
| 08/07/2002 | EP1228199A2 Method for directed packaging of molecular substances in protein shells |
| 08/07/2002 | EP1228193A2 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 08/07/2002 | EP1228097A2 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 08/07/2002 | EP1228096A1 Dog and rabbit motilin receptor orthologs |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228093A2 Improvement of peptide transport by conjugation with bile acids |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228090A2 Novel molecules and the card-related protein family and uses thereof |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1227848A2 Method for linking molecular substances |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1163340A4 Compositions and methods for the modification of gene expression |
| 08/07/2002 | EP1073763A4 Methods for transducing fusion molecules |
| 08/07/2002 | EP1027369A4 Methods of unfolding proteins using metal complexes |
| 08/07/2002 | EP0938728B1 Magnetizable device |
| 08/07/2002 | EP0906576B1 Prostate cancer specific antibodies for immunodetection and immunotherapy |
| 08/07/2002 | EP0823257B1 Medicinal composition for curing thrombocytopenia |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0762895B1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 08/07/2002 | EP0618976B1 Synthetic dna sequence having enhanced insecticidal activity in maize |
| 08/07/2002 | EP0536350B1 Identification of a novel human receptor tyrosine kinase gene |
| 08/07/2002 | CN1362992A Combination neisserial compositions |
| 08/07/2002 | CN1362969A Antimicrobial/endotoxin neutralizing polypeptide |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362967A Modulators for beta-amyloid peptide aggregation comprising D-amino acids |
| 08/07/2002 | CN1362520A Constitution process of blank expression system for transferring spider's dragline protein gene into Bombyx mori |
| 08/07/2002 | CN1362518A Hexulose phosphate isomerase and gene coding said isomerase |
| 08/07/2002 | CN1362417A Zinc-binding-force reinforced insulin derivative |
| 08/07/2002 | CN1362416A Production process of epidermal cell inhibitor with animal skin and its use |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/06/2002 | US6429362 Controlling gene expression of nucleotide sequences in heterologous plant; transformation, genetic engineering |
| 08/06/2002 | US6429360 Plant pest control |
| 08/06/2002 | US6429355 Hepatitis C animal model |
| 08/06/2002 | US6429354 Transgenic mouse whose genome has disruption in allele predisposing it to cancer or cell proliferation; medical diagnosis; gene expression |
| 08/06/2002 | US6429306 Library screening; restriction mapping, cloning, genetic engineering, gene expression; probes for diagnostic kits |
| 08/06/2002 | US6429305 Fish growth hormones |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429302 Polynucleotides related to pancreatic disease |
| 08/06/2002 | US6429300 Peptide acceptor ligation methods |
| 08/06/2002 | US6429299 Expression vectors for transgenic plants |
| 08/06/2002 | US6429298 Assays for identifying functional alterations in the p53 tumor suppressor |
| 08/06/2002 | US6429296 Complex of human growth hormone and zinc and use |
| 08/06/2002 | US6429293 Sculpin-type antifreeze polypeptides and nucleic acids |
| 08/06/2002 | US6429292 Glucuronide repressors and uses thereof |
| 08/06/2002 | US6429291 Hyaluronan receptor protein |
| 08/06/2002 | US6429290 Modulation of body weight; diagnosis; dietetics; gene expression; drug screening |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429286 Immunoregulatory molecules for costimulatory signal transduction |
| 08/06/2002 | US6429230 Treating chronic uremic patients undergoing periodical dialysis |
| 08/06/2002 | US6429201 Method for immunization against hepatitis B |
| 08/06/2002 | US6429193 Elution and purification of gingival fibroblast chemotactic factor (cctf) from bovine source; used to accelerate adhesion of new connective tissue between tooth and gum after periodontal surgery |
| 08/06/2002 | US6429192 Separating mannan-binding lectin (mbl) by affinity chromatography on non-conjugated cross-linked polysaccharide matrix and performing a validated virus reduction step |
| 08/06/2002 | US6429187 Method of diagnosing and treating gliomas |
| 08/06/2002 | US6429186 Ligand antagonists for treatment of breast cancer |
| 08/06/2002 | US6429011 Neuronal apoptosis inhibitor protein gene sequence and mutations causative of spinal muscular atrophy |
| 08/06/2002 | US6429010 Treating schizophrenia |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6429006 Use of recombinant yeasts expressing the lactate dehydrogenase gene so as to shift the glycolytic flux towards the production of lactic acid for greater yields |
| 08/06/2002 | US6428997 Aminopeptidase derived from Bacillus licheniformis and process for preparation of natural type proteins |
| 08/06/2002 | US6428988 (aav); first cre recombinase vector, second vector contains a promoter, spacer sequence flanked by loxp sites and rep/cap, and third vector containing a transgene and regulatory sequences flanked by aav inverted terminal repeats (itr) |
| 08/06/2002 | US6428985 Murine or human il-10 amino acid sequence, and wherein isoleucine at position 87 is replaced by one amino acid other than leucine or valine, converting it from an immunostimulant to an immunosuppresant |
| 08/06/2002 | US6428984 Cell disruption of hepatitis b surface antigen (hbsag)-expressing cells such as methylotrophic yeast cells using a high pressure homogenizer |
| 08/06/2002 | US6428982 Polynucleotides encoding mouse urotensin-II Receptor (UTB-R) |
| 08/06/2002 | US6428981 Expressing less than wild-type level of a gene termed yjbh produces increased yields of a polypeptide of interest |
| 08/06/2002 | US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing |
| 08/06/2002 | US6428978 Producing gelatin and genuine telopeptide collagen in yeasts or other cells by coexpression of dna constructs encoding alpha1(i) and alpha2(i) collagen monomers lacking the c and/or n propeptides |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428971 Genes and proteins related to this pathway include: teichoic acid polymerase (or tap), and cdp-glycerol:poly(glycerophosphate) glycerophosphotransferase; rodc gene and proteins |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |